(Q40069409)

English

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency

scientific article published in October 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency (English)

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

molecular design

0 references

0 references

author name string

Tsutsumi Y

1

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Tsunoda S

2

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Kamada H

3

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Kihira T

4

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Nakagawa S

5

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Kaneda Y

6

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Kanamori T

7

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Mayumi T

8

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

language of work or name

0 references

publication date

1 October 1996

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

74

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

7

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

1090-1095

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

22 September 2017

Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

22 September 2017

Phase I study of recombinant human tumor necrosis factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

22 September 2017

Phase I Evaluation of Recombinant Tumor Necrosis Factor Given in Combination With Recombinant Interferon-Gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

22 September 2017

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

22 September 2017

Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

22 September 2017

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

22 September 2017

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

22 September 2017

Enhancement of blood stasis and vascular permeability in Meth-A tumors by administration of hyperthermia in combination with tumor necrosis factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

25 September 2017

Phase I clinical trial of recombinant human tumor necrosis factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

25 September 2017

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

25 September 2017

Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

25 September 2017

Phase I study of recombinant tumor necrosis factor in cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

15 June 2018

The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

15 June 2018

Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

15 June 2018

Intravenous administration of polyethylene glycol-modified tumor necrosis factor-alpha completely regressed solid tumor in Meth-A murine sarcoma model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077111

20 August 2018

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequence dependence of administration of human recombinant tumor necrosis factor and interleukin-2 in murine tumor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of intratumoral application of recombinant human tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition characteristics of macromolecules in the perfused tissue-isolated tumor preparation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1996.495

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40069409&oldid=2203367554"